Patents by Inventor Isabelle Charlebois

Isabelle Charlebois has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Group B antigens
    Patent number: 8580262
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Grant
    Filed: July 16, 2012
    Date of Patent: November 12, 2013
    Assignee: ID Biomedical Corporation of Quebec
    Inventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
  • NOVEL GROUP B STREPTOCOCCUS ANTIGENS
    Publication number: 20130095498
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Application
    Filed: July 16, 2012
    Publication date: April 18, 2013
    Applicant: ID BIOMEDICAL CORPORATION OF QUEBEC
    Inventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
  • Group B antigens
    Patent number: 8226953
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Grant
    Filed: December 28, 2010
    Date of Patent: July 24, 2012
    Assignee: ID Biomedical Corporation of Quebec
    Inventors: Bernard R. Brodeur, Clement Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
  • NOVEL GROUP B STREPTOCOCCUS ANTIGENS
    Publication number: 20110182923
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Application
    Filed: December 28, 2010
    Publication date: July 28, 2011
    Applicant: ID BIOMEDICAL CORPORATION
    Inventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
  • Group B streptococcus antigens
    Patent number: 7914794
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Grant
    Filed: January 13, 2003
    Date of Patent: March 29, 2011
    Assignee: ID Biomedical Corporation
    Inventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
  • Polypeptides of
    Patent number: 7459165
    Abstract: The present invention relates to polypeptides of Pseudomonas aeruginosa which may be used to prevent, diagnose and/or treat Pseudomonas aeruginosa infection.
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: December 2, 2008
    Assignee: ID Biomedical Corporation
    Inventors: Nathalie Charland, Josee Hamel, Bernard Brodeur, Denis Martin, Isabelle Charlebois, Diane Bussiere
  • Polypeptides of pseudomonas aeruginosa
    Publication number: 20050107597
    Abstract: The present invention relates to polypeptides of Pseudomonas aeruginosa which may be used to prevent, diagnose and/or treat Pseudomonas aeruginosa infection.
    Type: Application
    Filed: November 13, 2002
    Publication date: May 19, 2005
    Inventors: Nathalie Charland, Josee Hamel, Bernard Brodeur, Denis Martin, Isabelle Charlebois, Diane Bussiere
  • Novel group B streptococcus antigens
    Publication number: 20030228323
    Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
    Type: Application
    Filed: January 13, 2003
    Publication date: December 11, 2003
    Inventors: Bernard R. Brodeur, Clement Rioux, Martine Boyer, Isabelle Charlebois, Josee Hamel, Denis Martin